[{"Assets_0_Q3_USD":2408627000.0,"CommonStockSharesOutstanding_0_Q3_shares":771063184.0,"EarningsPerShareBasic_1_Q3_USD":-0.19,"EarningsPerShareBasic_3_Q3_USD":-0.58,"EarningsPerShareDiluted_1_Q3_USD":-0.19,"EarningsPerShareDiluted_3_Q3_USD":-0.58,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-353823000.0,"NetIncomeLoss_1_Q3_USD":-144031000.0,"NetIncomeLoss_3_Q3_USD":-405514000.0,"StockholdersEquity_0_Q3_USD":1970446000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":739789269.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":703482491.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":739789269.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":703482491.0,"Ticker":"BGNE","CIK":"1651308","name":"BEIGENE, LTD.","OfficialName":"BeiGene Ltd. American Depositary Shares","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"18163188203.0","Country":"Cayman Islands","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181108"}]